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REPORT
Kinetochore phosphatases suppress autonomous
Polo-like kinase 1 activity to control the mitotic
checkpoint
Marilia H. Cordeiro*, Richard J. Smith*, and Adrian T. Saurin
Local phosphatase regulation is needed at kinetochores to silence the mitotic checkpoint (a.k.a. spindle assembly checkpoint
[SAC]). A key event in this regard is the dephosphorylation of MELT repeats on KNL1, which removes SAC proteins from the
kinetochore, including the BUB complex. We show here that PP1 and PP2A-B56 phosphatases are primarily required to
remove Polo-like kinase 1 (PLK1) from the BUB complex, which can otherwise maintain MELT phosphorylation in an
autocatalytic manner. This appears to be their principal role in the SAC because both phosphatases become redundant if PLK1 is
inhibited or BUB–PLK1 interaction is prevented. Surprisingly, MELT dephosphorylation can occur normally under these
conditions even when the levels or activities of PP1 and PP2A are strongly inhibited at kinetochores. Therefore, these data
imply that kinetochore phosphatase regulation is critical for the SAC, but primarily to restrain and extinguish autonomous PLK1
activity. This is likely a conserved feature of the metazoan SAC, since the relevant PLK1 and PP2A-B56 binding motifs have
coevolved in the same region on MADBUB homologues.
Introduction
The mitotic checkpoint, also known as the spindle assembly
checkpoint (SAC), prevents mitotic exit until chromosomes
have attached to microtubules via the kinetochore (Corbett,
2017; Saurin, 2018). MPS1 kinase initiates SAC signaling by
localizing to unattached kinetochores and phosphorylating
the SAC scaffold KNL1 on repeat motifs known as “MELT
repeats” (for the amino acid consensus Met-Glu-Leu-Thr;
London et al., 2012; Shepperd et al., 2012; Yamagishi et al.,
2012). Once phosphorylated, these MELT motifs recruit the
heterotetrameric BUB1:BUB3:BUB3:BUBR1 complex (hereaf-
ter BUB complex) to kinetochores (Overlack et al., 2015;
Primorac et al., 2013; Vleugel et al., 2013; Zhang et al., 2014),
which, directly or indirectly, recruits all other proteins
needed to activate the SAC and block mitotic exit (Corbett,
2017; Saurin, 2018). Once kinetochores attach to micro-
tubules, the local SAC signal must be rapidly extinguished by
at least three different mechanisms: (1) localized MPS1 ac-
tivity is inhibited (Aravamudhan et al., 2015; Hiruma et al.,
2015; Ji et al., 2015), (2) key phosphorylation sites, such as
the MELT repeats, are dephosphorylated by KNL1-localized
phosphatases (Espert et al., 2014; Espeut et al., 2012;
Meadows et al., 2011; Nijenhuis et al., 2014; Rosenberg et al.,
2011), and (3) dynein motors physically transport SAC
components away from kinetochores down microtubules
(Bader and Vaughan, 2010).
One key unexplained aspect of SAC signaling concerns the
role of Polo-like kinase 1 (PLK1; Combes et al., 2017). PLK1
interacts via its Polo-box domain (PBD) to phospho-epitopes
on various different kinetochore complexes, including two
CDK1 phosphorylation sites on the BUB complex (BUB1-pT609
and BUBR1-pT620; Elowe et al., 2007; Qi et al., 2006; Wong
and Fang, 2007). PLK1 has similar substrates preferences to
MPS1 (Dou et al., 2011; Hennrich et al., 2013), and it shares at
least two key substrates that are critical for SAC signaling: the
KNL1-MELT motifs and MPS1 itself, including key sites in the
MPS1 activation loop (Espeut et al., 2015; Ikeda and Tanaka,
2017; von Schubert et al., 2015). PLK1 can therefore enhance
MPS1 kinase activity and also directly phosphorylate the
MELT motifs to support SAC signaling, perhaps from its lo-
calized binding site on BUB1 (Ikeda and Tanaka, 2017). It is
unclear why PLK1 is needed to cooperate with MPS1 in SAC
signaling and, importantly, what inhibits PLK1 signaling to
allow MELT dephosphorylation and SAC silencing upon mi-
crotubule attachment. We set out to address these questions
by examining the role of the kinetochore-localized phospha-
tases PP1-KNL1 and PP2A-B56.
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PP1-KNL1 and PP2A-B56 antagonize PLK1 recruitment to the
BUB complex
Inhibition of PP1-KNL1 or knockdown of PP2A-B56 both enhance
PLK1 recruitment to kinetochores (Foley et al., 2011; Liu et al.,
2012). To test whether this was due to localized phosphatase
inhibition at the BUB complex, we inhibited the recruitment of
PP2A-B56 to BUBR1 (BUBR1ΔPP2A) and compared this to a PP1-
KNL1 mutant (KNL1ΔPP1), as used previously (Liu et al., 2012;
Nijenhuis et al., 2014; note that, in these and all subsequent
experiments, siRNA-mediated gene knockdown was used in
combination with doxycycline-inducible replacement of the WT
or mutant gene from an FRT locus; see Materials and methods).
This demonstrated that removal of either PP1 from KNL1 or
PP2A-B56 from BUBR1 increased PLK1 levels at unattached ki-
netochores (Fig. 1 A; nocodazole was added in these and all
subsequent experiments to prevent microtubule attachment
from indirectly affecting kinetochore signaling). We suspected
that the increased PLK1 was due to enhanced binding to the BUB
complex, because depletion of BUB1 and/or BUBR1 also removes
the BUBR1:PP2A-B56 complex from kinetochores, but this did
not enhance PLK1 levels (Fig. S1, A–C). In fact, kinetochore PLK1
was considerably reduced when the whole BUB complex was
removed (see siBUB1 + siBUBR1 in Fig. S1, A–C). PLK1 binds via
its PBD to CDK1 phosphorylation sites on BUB1 (pT609; Qi et al.,
2006) and BUBR1 (pT620; Elowe et al., 2007; Wong and Fang,
2007); therefore, we raised antibodies to these sites and vali-
dated their specificity in cells (Fig. S2, A–C). Immunofluores-
cence analysis demonstrated that phosphorylation of both sites
is enhanced at unattached kinetochores in KNL1ΔPP1 or
BUBR1ΔPP2A cells (Fig. 1, B and C; and Fig. S2, B–E). This is the
reason that PLK1 kinetochore levels increase when PP2A is re-
moved, because the elevated PLK1 levels can be attenuated by
BUBR1-T620A mutation (Fig. 1 D) and completely abolished by
additional mutation of BUB1-T609A (Fig. 1 E). Therefore, these
data demonstrate that PP1-KNL1 and BUBR1-bound PP2A-B56
antagonize PLK1 recruitment to the BUB complex by inducing
the dephosphorylation of key CDK1 phosphorylation sites on
BUBR1 (pT620) and BUB1 (pT609).
PP1-KNL1 and PP2A-B56 antagonize PLK1 to allow SAC
silencing
PLK1 is able to support SAC signaling by phosphorylating the
MELT motifs directly (Espeut et al., 2015; Ikeda and Tanaka,
2017; von Schubert et al., 2015). Therefore, we hypothesized
that the increased BUB–PLK1 levels in KNL1ΔPP1 and BUBR1ΔPP2A
cells could help to sustain MELT phosphorylation and the SAC
whenMPS1 is inhibited. To address this, we examined the effect
of PLK1 inhibition with BI-2536 under these conditions. Fig. 2, A
and B, and Fig. S3, A and B, show that MELT dephosphorylation
and mitotic exit are both attenuated following MPS1 inhibition
in nocodazole-arrested KNL1ΔPP1 or BUBR1ΔPP2A cells, as dem-
onstrated previously (Espert et al., 2014; Nijenhuis et al., 2014).
Importantly, however, these effects are rescued if PLK1 and
MPS1 are inhibited together (Fig. 2, C and D; and Fig. S3, C and D;
note the thick vertical bars in these violin plots display 95%
confidence intervals [CIs], which can be used for statistical
comparison of multiple time points/treatment by eye; see Ma-
terials and methods). Therefore, PLK1 is able to maintain the
SAC when MPS1 is inhibited in KNL1ΔPP1 or BUBR1ΔPP2A cells.
The sustained SAC phenotype in BUBR1ΔPP2A cells is due to en-
hanced PLK1 levels at the BUB complex, because MELT de-
phosphorylation and SAC silencing are also rescued if MPS1 is
inhibited when the PLK1 binding motif on BUBR1 is mutated
(BUBR1ΔPP2A-T620A; Fig. 2, E and F; and Fig. S3 E). Furthermore,
additional mutation of BUB1-T609A (BUBR1ΔPP2A-T620A +
BUB1T609A) is sufficient to revert phospho-MELT (pMELT) and
SAC strength to levels that are indistinguishable from WT cells
(Fig. 2, G and H; and Fig. S3, F–I). Importantly, removal of PLK1
alone from the BUB complex (BUBR1T620A + BUB1T609A) reduced
basal levels of pMELT and weakened the SAC, implying that the
pool of PLK1 that is bound to the BUB complex also enhances
basal SAC signaling (Fig. 2, G and H). Collectively, these data
demonstrate that PLK1 binds to the BUB complex to enhance
MELT phosphorylation, and kinetochore phosphatases must
antagonize this recruitment to allow the SAC to silence following
MPS1 inhibition. Although the majority of PLK1 is recruited to
BUBR1-pT620, there is significant pool that localizes to BUB1-
pT609, and removal of PLK1 from both BUBR1 and BUB1 causes
the greatest weakening of the SAC (Fig. 1, D and E; and Fig. 2 H).
BUB1–PLK1 locally amplifies KNL1-MELT signaling without
affecting MPS1 activity
As well as phosphorylating the MELT repeats, PLK1 can also
phosphorylate MPS1 to enhance its kinase activity (Combes
et al., 2018; Ikeda and Tanaka, 2017; von Schubert et al., 2015).
Therefore, PLK1 bound to the BUB complex could enhanceMELT
phosphorylation directly and/or indirectly by elevating MPS1
activity. The effects of PLK1 are apparent following MPS1 inhi-
bition, suggesting these effects are direct. However, pharma-
cological inhibition is never absolute; therefore, PLK1 could
simply enhanceMPS1 activity to increase the threshold required
for inhibition. To test this possibility, we probed the phospho-
rylation state of another kinetochore-localized MPS1 substrate
that contributes to SAC signaling: MAD1-pT716 (Allan et al.,
2020; Faesen et al., 2017; Ji et al., 2018; Ji et al., 2017). Fig. 3,
A–C, demonstrates that MAD1-pT716 is dephosphorylated with
identical kinetics when MPS1 is inhibited in the presence or
absence of kinetochore phosphatases, implying that kinetochore
phosphatases do not impact directly on MAD1-pT716 or more
generally on kinetochore MPS1 activity. This was surprising
given that removal of PP2A-B56 from BUBR1 has been shown
recently to enhance MPS1 T-loop phosphorylation and prevent
its dephosphorylation following MPS1 inhibition (Hayward
et al., 2019). However, it is possible that MPS1 inhibition with
2.5 μM AZ-3146 inhibits downstream MPS1 activity sufficiently,
irrespective of the level of MPS1 T-loop phosphorylation.
Therefore, we performed additional assays over a range of AZ-
3146 doses in BUBR1WT and BUBR1ΔPP2A cells. These experiments
demonstrated that MAD1-pT716 dephosphorylation is com-
pletely unaffected by a BUBR1ΔPP2A mutation (Fig. 3 D), even
though BUBR1 removal is strongly inhibited (Fig. 3 E), as ex-
pected due to the maintenance of MELT phosphorylation (Fig. 2,
A and B; Espert et al., 2014; Nijenhuis et al., 2014). Therefore,
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Figure 1. Kinetochore phosphatases PP1 and PP2A-B56 antagonize PLK1 recruitment to the BUB complex. (A–C) Effect of phosphatase-bindingmutants
on levels of PLK1 (A), BUBR1-pT620 (B), and BUB1-pT609 (C) at unattached kinetochores in nocodazole-arrested cells. Mean kinetochore intensities from
30–50 cells, three to five experiments. (D and E) Effect of mutating the PLK1 binding site on BUBR1 (pT620) alone (D) or BUBR1 (pT620) and BUB1 (pT609; E)
on PLK1 kinetochore levels in nocodazole-arrested BUBR1WT/ΔPP2A cells. Mean kinetochore intensities from 40 cells per condition, four experiments. All values
in E are normalized to BUBR1-WT+BUB1-WT control. For all kinetochore intensity graphs, each dot represents a cell, and the error bars display the variation
between the experimental repeats (displayed as ±SD of the experimental means). Two-tailed, nonparametric Mann-Whitney unpaired t tests were performed
to compare the mean values between experimental groups. Example immunofluorescence images were chosen that most closely resemble the mean values in
the quantifications. The insets show magnifications of the outlined regions. Scale bars, 5 µm. Inset size, 1.5 µm. ****, P < 0.0001; ns, nonsignificant.
Cordeiro et al. Journal of Cell Biology 3 of 16
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Figure 2. Kinetochore phosphatases PP1 and PP2A-B56 remove PLK1 from the BUB complex to silence the SAC. (A–D) Effects of phosphatase-binding
mutants on KNL1-MELT dephosphorylation (A and C) and duration of mitotic arrest (B and D) in nocodazole-arrested cells treated with MPS1 inhibitor AZ-3146
(2.5 µM) either alone (A and B) or in combination with the PLK1 inhibitor BI-2536 (100 nM; C and D). MG132 was included in all MELT phosphorylation
experiments to prevent mitotic exit after addition of the MPS1 inhibitor. A and C display kinetochore intensities from 30 cells per condition, three experiments.
Intensities are relative to CENP-C in BUBR1 cells or YFP-KNL1 in KNL1 cells, and all BUBR1 and KNL1 intensities are normalized to their respective WT, 0 min
time point. B and D show mean (±SD) of 150 cells per condition from three experiments. (E and F) Effect of mutating the PLK1 binding site on BUBR1 (pT620)
on MELT dephosphorylation (E) and mitotic exit (F) in nocodazole-arrested BUBR1WT/ΔPP2A cells, treated as in A and B. E displays kinetochore intensities of
Cordeiro et al. Journal of Cell Biology 4 of 16
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PLK1 activity increases on the BUB complex in BUBR1ΔPP2A cells,
and this is able to support MELT phosphorylation and SAC sig-
naling without affecting MPS1 activity toward another key SAC
substrate, MAD1.
Collectively, these data suggest that the BUB–PLK1 complex
functions as an autonomous kinase module that can bind to
phosphorylated MELT motifs and catalyze further MELT phos-
phorylation to locally amplify SAC signaling (Fig. 3 F). Multiple
MELT repeats are active on each KNL1 molecule (Vleugel et al.,
2015b; Vleugel et al., 2013; Zhang et al., 2014) and multiple
copies of KNL1 are present per kinetochore (Suzuki et al., 2015).
This creates >1,000 active MELT repeats on each human kine-
tochore, which an autonomous BUB1–PLK1 module can use to
rapidly amplify SAC signaling downstream of MPS1. Although
the benefit of this is likely to be rapid switch-like activation of
the SAC, it is important to antagonize this auto-catalytic module
to prevent SAC signaling from locking into a constitutive on
state. This is clearly an important role of kinetochore phospha-
tases because in the absence of either KNL1-PP1 or PP2A-B56,
PLK1 recruitment is enhanced (Fig. 1), and MELT phosphoryla-
tion and mitotic arrest can be maintained when MPS1 is strongly
inhibited (Figs. 2 and 3). This raises the important question of
whether PLK1 removal from the BUB complex is the only critical
role for these phosphatases in the SAC, or whether they are
additionally needed to dephosphorylate the MELT repeats, as
previously assumed (Espert et al., 2014; Espeut et al., 2012;
Meadows et al., 2011; Nijenhuis et al., 2014; Rosenberg et al.,
2011). There is an ∼5–10-min delay in MELT dephosphoryla-
tion betweenWT andKNL1ΔPP1/BUBR1ΔPP2A cells whenMPS1 and
PLK1 are inhibited together (blue versus red symbols in Fig. 2 C).
This could indicate a role for PP1/PP2A in MELT dephospho-
rylation, or alternatively, it may reflect the time it takes for
BI-2536 to penetrate cells and inhibit PLK1, since both inhibitors
were added together at time point zero in this assay. Therefore,
we next sought to dissect if localized PP1 or PP2A-B56 contribute
directly to MELT dephosphorylation.
KNL1-MELT dephosphorylation can still occur normally when
kinetochore PP1 and PP2A activities are strongly inhibited
PLK1 inhibition for 30min was sufficient to reduce basal pMELT
in KNL1ΔPP1 and BUBR1ΔPP2A cells to levels comparable with
WT cells (Figs. 4 A and S4 A). Therefore, we next examined
MELT dephosphorylation rates when MPS1 was inhibited im-
mediately after this 30-min inhibition of PLK1. Fig. 4 B and Fig.
S4, B and C, show that the MELT motifs are dephosphorylated
with very similar kinetics in this assay, irrespective of whether
PP1 or PP2A-B56 kinetochore recruitment is inhibited. This was
particularly surprising, because it implies that neither PP1 nor
PP2A is essential for dephosphorylating the MELT repeats. This
could reflect redundancy between the two phosphatases;
therefore, we attempted to remove both phosphatases from ki-
netochores by combining PP2A-B56 and PP1 knockdown (Fig. 4
C; and Fig. S4, D–F) or performing PP2A-B56 knockdown in
KNL1ΔPP1 cells (Fig. 4 D). However, in both of these situations,
MELT dephosphorylation was indistinguishable fromWT cells if
MPS1 and PLK1 were inhibited together. We also pretreated cells
with calyculin A, a very potent inhibitor of all PP1 and PP2A
phosphatases (IC50 values 1–2 nM; Ishihara et al., 1989). PP1/
PP2A were effectively inhibited by either a short 5-min pre-
treatment with 50 nM calyculin A or a longer 15-min pretreat-
ment with 25 nM calyculin A, because subsequent Aurora B
inhibition was unable to translocate RepoMan onto chromatin
(an event that depends on the dephosphorylation of RepoMan-
pS893 by localized PP1 or PP2A-B56; Fig. S5, A–D; Qian et al.,
2013). Note that these protocols pushed the level of PP1/PP2A
inhibition to the limit before the extent of cell rounding and
toxicity became too high. The toxic effect of PP1/PP2A inhibition
reflects the fact that these enzymes are central to most signaling
networks, and PP2A inhibition alone causes approximately half
of the phospho-proteome to change significantly (Kauko et al.,
2020). Notwithstanding these pleotropic effects, calyculin A is
still able to inhibit MELT dephosphorylation and BUB complex
removal following MPS1 inhibition alone, as expected (Fig. 4 E;
Fig. S5, E and F; and Fig. S6, A–C). Importantly, even in this
situation, the MELT motifs are still dephosphorylated, and the
BUB complex is removed with fast kinetics whenMPS1 and PLK1
are inhibited together. Note that there is a very slight delaywhen
PLK1 and MPS1 inhibitors are applied together in this assay, but
this delay is abolished by a 30-min pretreatment with the PLK1
inhibitor BI-2536, which is consistent with a similar effect seen
in BUBR1ΔPP2A and KNL1ΔPP1 cells (compare Figs. 2 C and 4 B). As
a final test, we combined genetic and pharmacological inhibition
by pretreating BUBR1ΔPP2A cells with calyculin A. Even under
these very stringent conditions, the MELT motifs are effectively
dephosphorylated when MPS1 and PLK1 are inhibited together
(Figs. 4 F and S6 D). There is a slight 5-min delay in dephos-
phorylation, and the baseline does not drop completely to zero
(after 10-min inhibition median, pMELT levels reduce by 97%,
from 1 to 0.03, in BUBR1-WT cells, and the reduction is 91%, from
1.72 to 0.16, in BUBR1ΔPP2A cells containing calyculin A;
Fig. 5 F). These small differences could reflect modest effects
of PP2A on MELT dephosphorylation, but given the strength
of PP2A inhibition under these conditions, and the fact that
43% of phospho-peptides are regulated by knockdown of PP2A
subunits alone (Kauko et al., 2020), we prefer the interpre-
tation that these effects are either off-target or due to elevated
30–80 cells per condition from three to seven experimental repeats. F shows the means (±SD) of 200 cells from four experiments. (G and H) Effect of mutating
both PLK1 binding sites BUBR1 (pT620) and BUB1 (pT609) on MELT dephosphorylation (G) and mitotic exit (H) in nocodazole-arrested cells, treated with MPS1
inhibitor AZ-3146 (2.5 µM in G and 1.25 µM in H). The 1.25 µM AZ dosewas selected because it is then possible to see effects that weaken or strengthen theWT
SAC response (2.5 µM AZ-3146 data are displayed in Fig. S3 I). G displays kinetochore intensities of 40 cells per condition from four experimental repeats, and
all intensities are normalized to BUBR1-WT+BUB1-WT control. H shows the means (±SEM) of 200–250 cells from four or five experiments. In all kinetochore
intensity graphs, each dot represents the mean kinetochore intensity of a cell, and the violin plots shows the distribution of intensities between cells. The thick
vertical lines represent a 95% CI around the median, which can be used for statistical comparison of multiple time points/treatments by eye (see Materials and
methods). Timelines indicate treatment regimen before fixation.
Cordeiro et al. Journal of Cell Biology 5 of 16
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Figure 3. PP1 and PP2A-B56 removal from kinetochores does not affect dephosphorylation of MAD1-pT716 following MPS1 inhibition. (A) Effects of
phosphatase-binding mutants on MAD1-pT716 dephosphorylation in nocodazole-arrested cells treated with MPS1 inhibitor AZ-3146 (2.5 µM), as indicated in
the timeline. Graph displays kinetochore intensities of 30 cells per condition from three experimental repeats. (B and C) Total MAD1 (B) and YFP (C) levels in
phosphatase-binding mutants treated as in A. B displays kinetochore intensities of 30 cells per condition from three experimental repeats, and C is derived
from 60 cells, six experiments. (D and E)MAD1-pT716 (D) and YFP-BUBR1 (E) kinetochore levels after 5 min of MPS1 inhibition with different concentrations of
AZ-3146 (0.3–5 µM) in nocodazole-arrested cells. Graphs display kinetochore intensities of 30 cells, three experiments. (F) Schematic model to illustrate how
PLK1 recruitment to multiple MELT motifs can amplify the SAC signal. M, MELT motif; BUBc, BUB complex; PP, PP2A-B56. In all kinetochore intensity graphs,
each dot represents the mean kinetochore intensity of a cell, and the violin plots shows the distribution of mean intensities between cells. The thick vertical
Cordeiro et al. Journal of Cell Biology 6 of 16
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kinase activity. For example, PLK1 and/or MPS1 activity may
be increased—both of these are known targets of PP2A
(Hayward et al., 2019; Kim et al., 2019; Wang et al., 2015)—or
other phospho-epitopes may be elevated that react with the
pMELT antibody.
In summary, these data imply that the primary role of PP1
and PP2A is to remove PLK1 from the BUB complex. This is
important because BUB1-bound PLK1 can otherwise prime its
own recruitment to maintain a key aspect of the SAC in an au-
tonomous manner (the final model is presented in Fig. 4 G). We
can find no evidence that either PP1 or PP2A-B56 are directly
required for MELT dephosphorylation, despite multiple at-
tempts to reduce activities as low as possible using a combina-
tion of phosphatase inhibition, knockdown, and/or binding
motif mutants. We acknowledge that phosphatase inhibition is
never absolute under any of these conditions; therefore, it is at
least conceivable that PP1 and/or PP2A are so efficient at MELT
dephosphorylation that we were unable to detect appreciable
effects by any of these treatments. However, we favor the in-
terpretation that an additional phosphatase, perhaps with un-
regulated basal activity, controls MELT dephosphorylation. We
therefore speculate that the regulated phosphatases (PP1/PP2A)
are primarily responsible for reducing kinase activity below a
threshold required to allow basal phosphatase activity to pre-
dominate and dephosphorylate the specific substrates (Fig. S7).
One advantage of using a constitutive basal phosphatase in this
situation is that it can reverse different signals in a synchronous
manner, irrespective of their positions within the kinetochore.
Thismay be difficult to achieve if the executioner phosphatase is
a regulated one that binds to a defined location within one
protein.
The PLK1 binding motif is conserved in metazoan
MADBUB homologues
The role of kinetochore phosphatases in MELT dephosphoryla-
tion and SAC silencing has been extensively documented in
different species (Benzi et al., 2020; Espert et al., 2014; Espeut
et al., 2012; London et al., 2012; Meadows et al., 2011; Nijenhuis
et al., 2014; Pinsky et al., 2009; Rosenberg et al., 2011; Roy et al.,
2019; Smith et al., 2019; Vallardi et al., 2019; Vanoosthuyse and
Hardwick, 2009). If removal of PLK1 from the BUB complex is a
common SAC silencing event in eukaryotes, then one would
expect to see coevolution between the phosphatase binding
motifs and PLK1 recruitment sites on BUBR1 and/or BUB1.
BUBR1/MAD3 and BUB1 are paralogues that arose following the
duplication and subfunctionalization of the ancestral MADBUB
gene (Tromer et al., 2016). We annotated a list of 152 published
eukaryotic MADBUB homologues (Tromer et al., 2016) to display
the positions of all consensus Polo binding motifs (PBMs; Ser-
Ser/Thr-Pro; Fig. S8; Elia et al., 2003). Note that this binding
motif, hereafter called PBM, can only bind PLK1 if accessible and
phosphorylated on the middle Ser/Thr residue; therefore, we
excluded any putative PBMs present in established function
domains/motifs.
The short linear motif (SLiM) that binds PP2A-B56, LxxIxE
(also known as KARD in BUBR1; Hertz et al., 2016; Suijkerbuijk
et al., 2012), is present primarily in opisthokonts, which includes
fungi and metazoa (Fig. S8). This contrasts with the RVSF SLiM,
which binds PP1 to KNL1 and is present throughout the eukar-
yotic tree of life (Kops et al., 2020; Tromer et al., 2015; van Hooff
et al., 2017; Fig. S8). PBMs are predicted to occur every 1 in 400
amino acids by chance; therefore, not surprisingly, they are also
present on a wide variety of eukaryotic MADBUBs (88/152
MADBUB homologues). However, there is an enrichment for
PBMs within MADBUBs that contain a KARD motif (56/63) and,
in particular, in metazoan lineages (35/37; Fig. S8). An unbiased
alignment of all eukaryotic PBMs by position, with respect to the
KARD, demonstrates a clear enrichment within the regions
surrounding, and often just before, the KARD (Fig. S9 A). Se-
quence alignment of all putative PBMs highlights a conserved
motif in a short stretch of ∼100 amino acids immediately before
the KARD, particularly in metazoan lineages (Fig. S9, B and C).
We propose that these are functional PBMs, and the entire
metazoan alignment is illustrated in Fig. 5, A–C.
This first notable feature of the PBM is its striking colocali-
zation with the KARD in the same region of MADBUB
throughout metazoa (Fig. 5 A and Fig. S9, A–C). The relative
activity of PP2A-B56 is strongly influenced by its position with
respect to its substrates, and the presence of Pro +1 relative to
pSer/Thr is a negative determinant for PP2A-B56 activity (Kruse
et al., 2020). Therefore, one interpretation is that the KARD
must be close enough to enable dephosphorylation of the PBMs,
which are otherwise predicted to be “poor” substrates. In rela-
tion to this, it is important to point out that although PP2A-B56
has low activity against Cdk1 sites (Kruse et al., 2020), this does
not mean that this phosphatase does not regulate these sites
during mitosis. In fact, quite the opposite; it may simply ensure
that the bulk of Cdk1 phosphorylation sites are unaffected by
constitutive PP2A-B56 activity, while then allowing a subset of
these sites to be dephosphorylated in a regulated manner by
SLiM-mediated colocalization. An alternative interpretation for
the PBM-KARD colocalization is that PLK1 must be close to the
KARD to allow subsequent phosphorylation of this motif. In
support of this hypothesis, the KARD contains a well-conserved
PLK1 phosphorylation site ([E/D]x[S/T]; Alexander et al., 2011;
Grosstessner-Hain et al., 2011; Nakajima et al., 2003) in a posi-
tion that is known to increase PP2A-B56 affinity when phos-
phorylated (LxxIxEx[S/T]; present in 55/61 eukaryotic and 36/37
metazoan homologues with an LxxIxEmotif: Fig. 5, A and C; and
Fig. S8; Kruse et al., 2013; Wang et al., 2016a; Wang et al., 2016b).
We hypothesize that both of these factors are important, and
that the juxtapositioning of the PLK1 and PP2A-binding motifs
lines represent a 95% CI around the median, which can be used for statistical comparison of multiple time point/treatments by eye (see Materials and
methods). Timelines indicate treatment regimen before fixation. MG132 was included in combination with MPS1 inhibitor in every case to prevent mitotic exit.
Representative images were chosen that most closely resemble the mean values in the quantifications. The insets show magnifications of the outlined regions.
Scale bars, 5 µm. Inset size, 1.5 µm.
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Figure 4. PP1/PP2A inhibition cannot prevent MELT dephosphorylation if MPS1 and PLK1 are inhibited together. (A and B) Effects of phosphatase-
binding mutants on KNL1-MELT dephosphorylation in nocodazole-arrested cells treated with PLK1 inhibitor BI-2536 (100 nM) alone (A) or in combination with
MPS1 inhibitor AZ-3146 (2.5 µM; B), as indicated in the timelines. Intensities are relative to CENP-C in BUBR1 cells or YFP-KNL1 in KNL1 cells, and all BUBR1 and
KNL1 intensities are normalized to their respective WT, 0 min time point. (C and D) KNL1-MELT phosphorylation levels following combined siRNA-mediated
knockdown of all PP1 and B56 isoforms (C) or all B56 isoforms in KNL1WT/ΔPP1 cells (D). The quantifications are from nocodazole-arrested cells treated with
MPS1 inhibitor AZ-3146 (2.5 µM) alone or in combination with PLK1 inhibitor BI-2536 (100 nM), as indicated. Representative images are displayed in Fig. S4, D
Cordeiro et al. Journal of Cell Biology 8 of 16
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has likely been conserved throughout evolution to allow PLK1/
PP2A-B56 cross-regulation on the BUB complex, the full im-
plications of which will be discussed later. It is important to just
note that PP2A-B56 interaction within BUBR1 can also regulate
phosphorylationwithin the PBM on BUB1 (BUBR1ΔPP2A increases
BUB1-pT609 in Fig. 1 C), implying that these motifs are close
enough to allow cross-regulation. This cross-regulation is also
likely to be a conserved feature of vertebrate MAD/BUB pa-
ralogues, because four of the annotated vertebrate species have a
MAD with a KARD and a BUB that has lost the KARD (Anolis
carolinensis [lizard], Ficedula albicollis [bird], Callorhinchus milii
[shark], and Lepisosteus oculatus [fish]; Fig. S8), and in all of these
cases, the BUB has maintained a conserved PBM (Fig. S9 D).
The second notable feature of the PBMs is a strict preference
for Thr over Ser in the Cdk1 phosphorylation position (Ser-Thr-
Pro in 34/35), which is not observed in other possible PBMs
elsewhere in MADBUB (Fig. S9, A–C). A Thr in this position is
not a general feature of other PBMs (Lowery et al., 2007) or Cdk1
phosphorylation sites (Holt et al., 2009), but it is thought to
confer enhanced activity toward PP2A, in comparison with
phospho-Ser (Cundell et al., 2016; Godfrey et al., 2017; Hein et al.,
2017; McCloy et al., 2015). We therefore hypothesized that this
may enhance activity toward the PBM motif and thereby allow
PP2A to antagonize PLK1 recruitment more efficiently. How-
ever, Thr-to-Ser conversions in either BUB1 (T609S) or BUBR1
(T620S) did not elevate PLK1 or pMELT levels, either at baseline
or after MPS1 inhibition (Fig. S10, A–F). Rather, BUB1-T609S
mutation caused a slight reduction in baseline kinetochore PLK1
and pMELT levels and weakened the SAC response (Fig. S10,
D–H). We were not able to measure phosphorylation status di-
rectly in these mutants, therefore we cannot assess if phos-
phorylation was increased, as predicted. However, given that
PLK1 levels are not increased, but instead slightly decreased, we
conclude that Thr is required in the PBM to optimize PLK1
binding (and perhaps turnover) to allow efficient SAC signaling.
A final striking feature of the core PBM is the conserved
stretch of hydrophobic residues before and immediately after
the Ser-Thr-Pro motif. PLK1 has recently been shown to use a
conserved hydrophobic pocket that lies adjacent to the phospho-
substrate binding groove to enhance substrate binding affinity
(Sharma et al., 2019). Although this pocket is often found in a
closed conformation, it also exhibits a variety of crystal packing
interactions with hydrophobic residues, demonstrating a high
degree of flexibility (Śledź et al., 2011). Two examples of natural
phospho-dependent binders that use this pocket are CENP-U/
PBIP1, which interacts via Phe71 (F71DPPLHS[pT]A; Kang et al.,
2006; Śledź et al., 2011), and Partner of Numb (PON), which uses
Phe60 (CFTNAAF60SS[pT]P) to bind to the pocket and lock an
interaction between two adjacent PBDs, resulting in PLK1 di-
merization and activation (Zhu et al., 2016). Interestingly, the
CENP-U interaction also appears to dimerize PLK1 (Musacchio,
A., personal communication). Therefore, we propose that the
conserved hydrophobic amino acids within the MADBUB PBM
act to stabilize PLK1 binding, and perhaps additionally to allow
PLK1 dimerization and activation at kinetochores. In support of
this idea, targeting the hydrophobic pocket on PLK1 directly,
using mutations or small molecule inhibition, causes reduced
PLK1 recruitment to kinetochores and a mitotic arrest associated
with misaligned chromosomes (Sharma et al., 2019). We hy-
pothesize that impaired interaction of PLK1 with the BUB com-
plex is at least partially responsible for these phenotypes. A final
parallel between MADBUB and CENP-U/PON is the presence of
putative PLK1-regulated PP2A-B56 interaction motifs upstream
of the PBMs (Fig. 5 D). It will be important to test whether PP2A-
B56 and PLK1 engage in similar cross-regulation at CENP-U/
PON, as observed here at the BUB complex, and to examine
whether PLK1 dimerizes on the BUB complex, as it does on
CENP-U/PON. If similar features have evolved separately in
different complexes, then this would imply functional conser-
vation of a PLK1-PP2A module that can be repurposed on dif-
ferent complexes to carry out distinct functions. In relation to
this, it is important to point out that PLK1-PP2A cross-regulation
on the BUB complex may also regulate other processes as well as
the SAC. In particular, kinetochore-microtubule attachments are
inhibited by PP2A-B56 loss but rescued by subsequent inhibition
of PLK1 (Foley et al., 2011); therefore, we speculate that PLK1-
PP2A cross-regulation on the BUB complex may also impact the
microtubule attachment process, perhaps by regulating kineto-
chore Aurora B activity. This will be an important future area of
investigation because it may help to explain why this bifunc-
tional kinase-phosphatase module is so well conserved.
Notwithstanding potential effects on other processes, a major
role of PLK1-PP2A cross-regulation on the BUB complex is to
control SAC activation and silencing. We demonstrate here that
PP2A-B56 is required to antagonize BUB1–PLK1 binding and
thereby suppress an autonomous kinase module that can oth-
erwise enhance SAC signaling (pMELT→BUB:PLK1→pMELT;
Fig. 5 E, P1). We showed recently that PP2A-B56 is unable to
silence the SAC on its own, primarily because it binds to BUBR1
in a phospho-dependent manner (Smith et al., 2019). Consider-
ing that PLK1 removal is the crucial event in SAC silencing and
PLK1 enhances PP2A-B56 recruitment (Elowe et al., 2007; Kruse
et al., 2013; Suijkerbuijk et al., 2012; Xu et al., 2013), we speculate
that this negative feedback loop operates on the BUB complex
and G. (E) KNL1-MELT dephosphorylation in Hela FRT cells arrested in nocodazole treated with kinase inhibitors in the presence or absence of the PP1/PP2A
phosphatase inhibitor calyculin A (25 nM), as indicated. Representative images are displayed in Fig. S4 H. (F) Effects of PP2A-binding mutants in combination
with the PP1/PP2A phosphatase inhibitor calyculin A (25 nM) on pMELT dephosphorylation in nocodazole-arrested cells treated with PLK1 (100 nM BI-2536)
andMPS1 (2.5 µM AZ-3146) inhibitors, as indicated in the timeline. Representative images are displayed in Fig. S4 I. In all kinetochore intensity graphs, each dot
represents the mean kinetochore intensity of a cell, and the violin plots shows the distribution of mean intensities between cells. The thick vertical lines
represent a 95% CI around themedian, which can be used for statistical comparison of multiple time point/treatments by eye (seeMaterials andmethods). A–D
derived from 30–40 cells per condition, three or four experiments. E and F display 40–50 cells, four or five experiments. Timelines indicate treatment regimen
before fixation. MG132 was included in whenever MPS1 was inhibited to prevent mitotic exit. (G) Schematic model to show how kinetochore phosphatases
restrain (PP2A) or extinguish (PP1) autonomous PLK1 activity to control the SAC. MCC, mitotic checkpoint complex.
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and limits the ability of PP2A-B56 to fully silence the SAC
(PP2AxPLK1→PP2A; Fig. 5 E, N1). To test this model, it will be
important to evaluate how local PLK1 levels affect PP2A-B56
recruitment to the BUB complex. Homeostatic SAC regulation by
phospho-dependent PP2Amay be important to preserve the BUB
complex at kinetochores when microtubules attach in a mono-
riented fashion and MPS1 is removed/inhibited (Aravamudhan
et al., 2015; Hiruma et al., 2015; Ji et al., 2015). The benefit of
preserving the SAC platform in this situation is that SAC sig-
naling can then be rapidly reestablished if microtubules subse-
quently detach. However, if the correct bioriented state is
achieved and the kinetochore comes under tension, then the PP1
arm is engaged (Liu et al., 2010), which, crucially, is not re-
stricted by negative feedback (Fig. 5 E). In fact, we speculate that
this tension-dependent switch is reinforced by positive feedback
instead, because removal of PLK1 and the BUB complex is pre-
dicted to reduce centromeric Aurora B activity (Combes et al.,
2017; Hindriksen et al., 2017), thereby enhancing PP1-KNL1 re-
cruitment (PP1xBUB:PLK1→ Aurora BxPP1; not depicted in
Fig. 5 E). An important feature of this model is that PP1 and
PP2A-B56 exhibit no intrinsic specificities, but rather, they
produce different network effects due to their opposite
phospho-dependencies; as previously illustrated with the aid of
mathematical modeling (Smith et al., 2019). It will be important
to update this model to include the PLK1 regulation demon-
strated here; a crucial aspect of which will be to determine
whether PP1 or PP2A-B56 activities against the BUBR1-pT620
and/or BUB1-pT609 sites are equivalent.
In summary, by interrogating the specific role of PP1 and
PP2A-B56 at kinetochores, we arrive at the conclusion that
phosphatase regulation is critical, but primarily to restrain
and extinguish localized kinase activity. It will be important
in the future to verify whether this is their only critical role in
the SAC, and if so, what phosphatase(s) dephosphorylate the
MELT motifs. It is interesting to note that other organisms
have evolved different circuits to control the SAC, but even in
these cases, phosphatase regulation appears to focus back to
limit kinase activity. In flies, the phospho-Thr residues on the
KNL1-MELT motifs are not conserved, and MPS1/PLK1 activ-
ities are not required to recruit the BUB complex to kineto-
chores (Conde et al., 2013; Schittenhelm et al., 2009).
However, in this situation, PP1 binds directly to MPS1 to in-
hibit its activity and silence the downstream SAC signal
(Moura et al., 2017). Therefore, the use of regulated phos-
phatases to silence local kinase activity may be a conserved
feature of SAC signaling.
Materials and methods
Cell culture
All cell lines were derived from HeLa Flp-in cells (a gift from S.
Taylor, University of Manchester, Manchester, UK; Tighe et al.,
2008) and authenticated by STR profiling (Eurofins). The cells
were cultured in DMEM supplemented with 9% FBS (Gibco) and
50 µg/ml penicillin/streptomycin (Thermo Fisher). During flu-
orescence time-lapse analysis, cells were cultured in DMEM (no
phenol red) supplemented with 9% FBS and 50 µg/ml penicillin/
streptomycin. Cells were screened every 4–8 wk to ensure they
were mycoplasma free.
Plasmids and cloning
pcDNA5-YFP-BUBR1WT expressing an siRNA-resistant and
N-terminally YFP-tagged WT BUBR1 and pcDNA5-YFP-
BUBR1ΔPP2A (also called BUBR1ΔKARD) lacking amino acids
663–680 were previously described (Nijenhuis et al., 2014).
These vectors were used to generate pcDNA5-YFP-BUBR1T620A,
pcDNA5-YFP-BUBR1ΔPP2A-T620A, and pcDNA5-YFP-BUBR1T620S
by site-directed mutagenesis using the following primers
(Sigma-Aldrich): T620A (forward 59-TGCCAGAGCAGCTCGTTT
TGTATCCGCTCCTTTTCATGAGATAATGTCCTTG-39, reverse 59-
CAAGGACATTATCTCATGAAAAGGAGCGGATACAAAACGAGC




an siRNA-resistant and N-terminally YFP-tagged WT BUB1 was
described previously (Vleugel et al., 2015a) and used to gen-
erate pcDNA5-YFP-BUB1T609A and pcDNA5-YFP-BUB1T609S by
site-directed mutagenesis using the following primers (Sigma-
Aldrich): T609A (forward 59-CACATCTGCTGCACAACTTGC
GTCTGCACCATTCCACAAGCTTCCAGTGG-39, reverse 59-CCA
CTGGAAGCTTGTGGAATGGTGCAGACGCAAGTTGTGCAGCAG




pcDNA5-Turq2-BUB1T609A were created by restriction cloning
using Acc65I and BstBI to replace the YFP originally present
in pcDNA5-YFP-BUB1WT and pcDNA5-YFP-BUB1T609A (Turq2
subcloned from pcDNA4-mTurq2-BUBR1WT; Smith et al., 2019).
pcDNA5-YFP-KNL1WT expressing an siRNA-resistant and
N-terminally YFP-tagged WT KNL1 and pcDNA5-YFP-KNL1ΔPP1
(with RVSF at amino acids 58–61 mutated to AAAA, also called
KNL14A) were previously described (Smith et al., 2019).
pcDNA5-YFP-RepoManWT expressing an siRNA-resistant and
N-terminally YFP-tagged WT RepoMan was subcloned by re-
striction cloning (with NotI/ApaI) to replace BUBR1 in pcDNA5-
YFP-BUBR1WT using a synthesized DNA fragment containing
the human RepoMan sequence flanked by NotI/ApaI restriction
sites (Baseclear). The siRNA-resistant mutations were TGACcG
AtcTaACtcGgAA (small letters indicate silent base changes). All
plasmids were fully sequenced to verify the transgene was
correct.
Gene expression
HeLa Flp-in cells were used to stably express doxycycline-
inducible constructs after transfection with the relevant
pcDNA5/FRT/TO vector and the Flp recombinase pOG44
(Thermo Fisher). Cells were then selected for stable integrants
at the FRT locus using 200 µg/ml hygromycin B (Santa Cruz
Biotechnology) for at least 2 wk. In experiments requiring two
transgenes in Fig. 1 E; Fig. 2, G and H; and Fig. S3, F–I, YFP-
BUBR1-WT, ΔPP2A, ΔPP2A-T620A, or T620A was transiently
transfected into cells stably expressing doxycycline-inducible
Cordeiro et al. Journal of Cell Biology 10 of 16
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Turq2-BUB1-WT or T609A mutants. Transfection with these
YFP-tagged constructs was done 32 h before endogenous gene
knockdown (described below) and at least 72 h before fixation.
Plasmids were transfected using Fugene HD (Promega) ac-
cording to the manufacturer’s instructions.
Gene knockdown
For all experiments in HeLa Flp-in cells, the endogenous mRNA
was knocked down and replaced with an siRNA-resistant mu-
tant. The siRNAs used in this study were BUBR1 (59-AGAUCC
UGGCUAACUGUUC-39), siBUB1 (59-GAAUGUAAGCGUUCACGA
Figure 5. Evolution of PBMs and PP2A-B56 binding motifs (KARD) in MADBUB homologues. (A) Annotation of PBMs (Ser-Ser/Thr-Pro) and PP2A-B56
binding motifs (LxxIxE, KARD) positions within metazoan MADBUB homologues that contain a KARD. Adapted from Tromer et al. (2016); see Fig. S8 and Data
S1 for complete list of 152 eukaryotic MADBUB homologues. (B) Alignment of proposed PBM (located immediately before the KARD) in the species represented
in A. (C) Consensus sequence of PBMs listed in B (for consensusmotif of other PBMs within eukaryotic MADBUB homologues, see Fig. S9) and the KARDwithin
all eukaryotic MADBUB homologues. (D) Alignment of PBM and KARD in BUBR1, BUB1, PON, and CENP-U. Note: PON is a Drosophila gene with no known
homologues in humans, which is involved in mitotic asymmetric division during Drosophila brain development (Lu et al., 1998). (E) Schematic model to illustrate
relevant feedback loops involved in SAC activation and silencing (see Results and discussion for explanations). KT-MT, kinetochore-microtubule.
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A-39), B56α (PPP2R5A: 59-UGAAUGAACUGGUUGAGUA-39),
B56β (PPP2R5B: 59-GAACAAUGAGUAUAUCCUA-39), B56γ
(PPP2R5C: 59-GGAAGAUGAACCAACGUUA-39), B56δ (PPP2R5D:
59-UGACUGAGCCGGUAAUUGU-39), B56ε (PPP2R5E: 59-GCA
CAGCUGGCAUAUUGUA-39), PP1α (PP1CA: 59-GUAGAAACCAUA
GAUGCGG-39), PP1β (PP1CB: 59-ACAUCAGUAGGUCUCAUAA-
39), PP1γ (PP1CC: 59-GCAUGAUUUGGAUCUUAUA-39), RepoMan
(59-UGACAGACUUGACCAGAAA-39), and GAPDH (control siRNA:
59-GUCAACGGAUUUGGUCGUA-39). All siRNAs were synthe-
sized with dTdT overhang by Sigma-Aldrich and used at 20 nM
final concentration (i.e., the pools for B56 or PP1 knockdown
contain 20 nM of each siRNA). Double-stranded interference
RNA was used to knock down endogenous KNL1 (sense: 59-GCA
UGUAUCUCUUAAGGAAGAUGAA-39; antisense: 59-UUCAUC
UUCCUUAAGAGAUACAUGCAU-39; Integrated DNA Technolo-
gies) at a final concentration of 20 nM. All siRNAs/double-
stranded interference RNAswere transfected using Lipofectamine
RNAiMAX Transfection Reagent (Life Technologies) according to
the manufacturer’s instructions.
After 16 h of knockdown, DNA synthesis was prevented by
addition of thymidine (2 mM; Sigma-Aldrich) for 24 h. Dox-
ycycline (1 µg/ml; Sigma-Aldrich) was used to induce ex-
pression of the BUBR1, BUB1, RepoMan, and KNL1 constructs
during and following the thymidine block. Cells were then
released from thymidine block into media supplemented with
doxycycline and nocodazole (3.3 µM; Sigma-Aldrich) for 8.5 h
before processing for fixed analysis. In live-cell imaging ex-
periments in Fig. 2, MPS1 and/or PLK1 were inhibited by
adding AZ-3146 (2.5 µM; Sigma-Aldrich; Hewitt et al., 2010)
and BI-2536 (100 nM; Selleckbio; Steegmaier et al., 2007)
shortly before imaging (6–8 h after thymidine release). For
MPS1 and PLK1 inhibition in cells analyzed by immunofluo-
rescence, nocodazole and MG132 (10 µM; Sigma-Aldrich) were
added first for 30 min (plus BI-2536 if pretreatment was
used), followed by a time course of AZ-3146 and/or BI-2536 in
media containing nocodazole and MG132.
A high dose of calyculin A (25 nM or 50 nM; LC Laboratories)
was used to inhibit all PP1 and PP2A phosphatases (IC50 values
1–2 nM; Ishihara et al., 1989). In these experiments (Fig. 4 E; Fig.
S5, E and F; and Fig. S6, A–C), Hela FRT cells (empty FRT locus)
were treated with nocodazole for 4 h followed by a 30-min in-
cubation with media containing nocodazole and MG132 (these
two drugs were present in all the subsequent steps of these
experiments) before treatment as indicated in the timelines.
Efficient phosphatase inhibition was confirmed in similar assays
(Fig. S5, A–D) by testing the ability of RepoMan to translocate to
chromatin after inhibition of Aurora B activity with 2 µM ZM-
447439 (Cayman Chemicals; Ditchfield et al., 2003).
To image nocodazole-arrested cells treated with siRNA
targeting BUBR1, BUB1, or both (Fig. S1, A–C), HeLa FRT cells
were released from thymidine block (40 h after siRNA treat-
ment) for 7 h before arresting at the G2/M boundary with RO-
3306 treatment (10 mM; Tocris) for 2 h. Cells were then
washed three times and incubated for 15 min with full growth
media before addition of MG132 for 30 min to prevent mitotic
exit. This is important so that cells enter mitosis in the
presence of nocodazole and MG132, which allows the arrest to
be maintained and Cyclin B levels to be preserved, even
though the SAC is inhibited. Cells were then fixed and stained
as described below.
Immunofluorescence
Cells, plated on High Precision 1.5H 12-mm coverslips (Mar-
ienfeld), were fixed with 4% PFA in PBS for 10 min or preex-
tracted (when using BUB1-pT609 or BUBR1-pT620 antibodies
and in double mutant experiments) with 0.1% Triton X-100 in
PEM (100 mM Pipes, pH 6.8, 1 mMMgCl2, and 5 mM EGTA) for
1 min before addition of 4% PFA for 10min. In experiments using
calyculin A, coverslips were coated with poly-L-lysine (Sigma-
Aldrich) to prevent cell loss. After fixation, coverslips were
washed with PBS and blocked with 3% BSA in PBS + 0.5% Triton
X-100 for 30 min, incubated with primary antibodies overnight
at 4°C, washed with PBS, and incubated with secondary anti-
bodies plus DAPI (Thermo Fisher) for an additional 2–4 h at
room temperature in the dark. Coverslips were then washed
with PBS and mounted on glass slides using ProLong antifade
reagent (Molecular Probes). All images were acquired on a
DeltaVision Core or Elite system equipped with a heated 37°C
chamber, with a 100×/1.40NAU Plan S Apochromat oil objective
using softWoRx software (Applied Precision). Images were ac-
quired at 1 × 1 binning using a CoolSNAP HQ or HQ2 camera
(Photometrics) and processed using softWorx software (decon-
volution followed bymaximum projection) and ImageJ (National
Institutes of Health). For experiments involving YFP-expressing
cells, mitotic cells were selected based on good expression of YFP
at the kinetochore (KNL1) or cytoplasm (BUBR1 cells). In cases
where double mutants (YFP and Turquoise 2) were used (Fig. 1
E, Fig. 2 G, and Fig. S3, F–H), cells were selected based on good
YFP signal in the kinetochore and cytoplasm, since the chicken
anti-GFP antibody used cannot discriminate between the two
fluorescent proteins. All immunofluorescence images displayed
are maximum intensity projections of deconvolved stacks and
were chosen to most closely represent the mean quantified data.
Figure panels were creating using Omero (http://openmicroscopy.
org).
Time-lapse analyses
For fluorescence time-lapse imaging, cells were imaged in 24-
well plates in DMEM (no phenol red) with a heated 37°C
chamber in 5% CO2. Images were taken every 4 min with a 20×/
0.4 NA air objective using a Zeiss Axio Observer 7 with a CMOS
Orca flash 4.0 camera at 4 × 4 binning. For brightfield imaging,
cells were imaged in a 24-well plate in DMEM in a heated
chamber (37°C and 5% CO2) with a 10×/0.5 NA air objective
using a Hamamatsu ORCA-ER camera at 2 × 2 binning on a Zeiss
Axiovert 200M, controlled by Micro-manager software (open
source; https://micro-manager.org/) or with a 20×/0.4 NA air
objective using a Zeiss Axio Observer 7 as detailed above. Mitotic
exit was defined by cells flattening down in the presence of
nocodazole and MPS1 inhibitor. In double mutant assays where
both recombinant BUBR1 and BUB1 are expressed (Figs. 2 H and
S3 I), cells were selected for quantification based on high levels
of YFP as an indication of successful transient transfection of
BUBR1 constructs.
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All antibodies were diluted in 3% BSA in PBS. The following
primary antibodies were used for immunofluorescence imaging
(at the final concentration indicated): chicken anti-GFP (ab13970
from Abcam, 1:5,000), guinea pig anti–CENP-C (PD030 from
Caltag + Medsystems, 1:5,000), rabbit anti-BUB1 (A300-373A
from Bethyl, 1:1,000), mouse anti-BUBR1 (05–898 from Milli-
pore, 1:1,000), rabbit anti-PLK1 (IHC-00071 from Bethyl,
1:1,000), mouse anti-KNL1 (gift from M. Yanagida, Okinawa
Institute of Science and Technology Graduate University, Oki-
nawa, Japan, 1:500), rabbit anti-KNL1 (ab70537 from Abcam,
1:500), mouse anti-MAD1 (MABE867 from Millipore, 1:1,000),
rabbit anti–MAD1-pT716 (Allan et al., 2020; custom raised by
Biomatik, 1:1,000), and rabbit anti-BUBR1 (A300-386A from
Bethyl, 1:1,000). The rabbit anti–pMELT-KNL1 antibody is di-
rected against Thr 943 and Thr 1155 of human KNL1 (Nijenhuis
et al., 2014; 1:1,000). The rabbit anti–BUB1-p609 antibody was
raised against phospho–Thr 609 of human BUB1 using the fol-
lowing peptide C-AQLAS[pT]PFHKLPVES (custom raised by
Biomatik, 1:1,000). The rabbit anti–BUBR1-p620 antibody was
raised against phospho–Thr 620 of human BUBR1 using the
following peptide C-AARFVS[pT]PFHE (custom raised by
Moravian, 1:1,000). Secondary antibodies used were highly
cross-absorbed goat, anti-chicken Alexa Fluor 488 (A-11039),
anti-rabbit Alexa Fluor 568 (A-11036), anti-mouse Alexa Fluor
488 (A-11029), anti-mouse Alexa Fluor 568 (A-11031), or anti–
guinea pig Alexa Fluor 647 (A-21450), all used at 1:1,000
(Thermo Fisher).
The following antibodies were used for Western blotting (at
the final concentration indicated): rabbit anti-GFP (custom
polyclonal, a gift from G. Kops, Hubrecht Institute, Utrecht,
Netherlands, 1:5,000), rabbit anti-BUBR1 (A300-386A from
Bethyl, 1:1,000), rabbit anti-BUB1 (A300-373A from Bethyl,
1:1,000), rabbit anti–BUB1-p609 (custom raised by Biomatik,
1:1,000), rabbit anti–BUBR1-p620 (custom raised by Moravian,
1:1,000) and mouse anti–α-tubulin (clone B-5-1-2, T5168, Sigma-
Aldrich, 1:10,000). Secondary antibodies used were goat anti-
mouse IgG HRP conjugate (170–6516 from Bio-Rad, 1:2,000)
and goat anti-rabbit IgG HRP conjugate (170–6515 from Bio-Rad,
1:5,000).
Immunoprecipitation and immunoblotting
Flp-in HeLa cells were treated with thymidine and doxycycline
for 24 h, followed by a treatment with nocodazole and doxycy-
cline for 16 h. Mitotic cells were isolated by mitotic shakeoff and
incubated with media containing nocodazole and doxycycline
with or without calyculin A (50 nM; LC Laboratories) for
20 min. Cells were lysed in lysis buffer (50 mM Tris, pH 7.5,
150 mM NaCl, 0.5% Triton X-100, 1 mM Na3VO4, 5 mM
β-glycerophosphate, 25 mM NaF, 10 nM calyculin A, and com-
plete protease inhibitor containing EDTA; Roche) on ice for
20min. The lysate was incubated with GFP-Trapmagnetic beads
(from ChromoTek) for 2 h at 4°C on a rotating wheel in wash
buffer (same as lysis buffer, but without Triton X-100) at a 3:2
ratio of wash buffer:lysate. The beads were washed three times
with wash buffer, and the sample was eluted according to the
protocol from ChromoTek.
Image quantification and statistical analysis
For quantification of kinetochore protein levels, images of sim-
ilarly stained experiments were acquired with identical illumi-
nation settings and analyzed using an ImageJ macro, as
described previously (Saurin et al., 2011). Briefly, the ImageJ
macro uses autothreshold to select all kinetochores and all
chromosome areas (excluding kinetochores) using the DAPI and
anti-kinetochore antibody channels (CENP-C), respectively. This
was used to calculate the relative mean kinetochore intensity of
various proteins ([kinetochore–chromosome arm intensity (test
protein)]/[kinetochore–chromosome arm intensity (CENP-C)]).
RepoMan translocation to chromatin was quantified by deter-
mining the mean intensity of YFP in the chromatin (defined by
autothreshold in the DAPI channel) and cytoplasm (remaining
cell excluding the DAPI area) and plotted as a ratio chromatin/
cytoplasm signal. Normality of the data distribution was
tested using the D’Agostino & Pearson normality test. Two-
tailed, nonparametric Mann-Whitney unpaired t tests were
performed to compare the means values between experi-
mental groups in immunofluorescence quantifications from
Figs. 1, S1, and S2 (using Prism 6 software). For Fig. 2 onward,
when multiple time points and treatments are used to com-
pare the difference in dephosphorylation kinetics, the graphs
are plotted as violin plots using PlotsOfData (Postma and
Goedhart, 2019; https://huygens.science.uva.nl/PlotsOfData/).
This allows the spread of data to be accurately visualized along
with the 95% CIs (thick vertical bars) calculated around the
median (thin horizontal lines). Statistical comparison can then
be made by eye between any treatment and time points, because
when the vertical bar of one condition does not overlap with one
in another condition, the difference between the medians is
statistically significant (P < 0.05). In KNL1 cells, kinetochore
intensities were normalized to YFP-KNL1 to avoid artificial
fluctuation of signal resulting from variability in reexpression
levels of YFP-KNL1.
PLK1 binding motifs analysis in eukaryotic
MADBUB homologues
The dataset from Tromer et al., 2016 was used and annotated for
the presence of PBM (Ser-Ser/Thr-Pro; Elia et al., 2003), ex-
cluding any putative motifs present in established function do-
mains/motifs. The full list of annotated and excluded PBMs is
included in Data S1. The majority of KNL1 sequences used to
determine presence/absence of the KNL1-RVSF were published
previously (Kops et al., 2020; Tromer et al., 2015; van Hooff
et al., 2017). Any unannotated genomes were searched by blast
using KNL1 orthologues from the closest species. The additional
KNL1 orthologues found by this approach are included in Data
S2. Consensus binding motifs in Figs. 5 C and S9 were created
using WebLogo (Crooks et al., 2004; https://weblogo.berkeley.
edu/logo.cgi). Protein alignments were generated using Jalview
(Waterhouse et al., 2009).
Online supplemental material
Fig. S1 shows the effect of BUB1/BUBR1 knockdown in PLK1,
BUBR1, and BUB1 levels. Fig. S2 shows the specificity of phospho-
specific antibodies BUB1-pT609 and BUBR1-pT620 in cells and
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the levels of BUB1 and BUBR1 in phosphatase-binding mutants.
Fig. S3 shows representative images of the data represented in
Fig. 2, KNL1 levels duringMPS1/PLK1 inhibition, andmitotic exit
in BUBR1T620A+BUB1T609A mutants with 2.5 µM AZ-3146. Fig. S4
shows example images of kinetochore quantifications and KNL1
and BUBR1 levels in cells treated as in Fig. 4. Fig. S5 shows ki-
netochore quantification of BUBR1 and RepoMan after calyculin
A treatment with 25 nM and 50 nM doses. Fig. S6 shows kine-
tochore quantification of KNL1 and KNL1-pMELT after calyculin
A treatment with 25 nM and 50 nM doses. Fig. S7 shows a model
for how localized processes could use a combination of regulated
and unregulated phosphatase activity to synchronously de-
phosphorylate spatially resolved substrates. Fig. S8 describes the
presence or absence of PBMs and PP2A-B56 binding motifs
(KARD) within eukaryotic MADBUB homologues and PP1-
binding motifs (RVSF) within KNL1 orthologues. Fig. S9 shows
sequence alignment of all PBM in eukaryotic MADBUB homo-
logues with respect to position from the KARD. Fig. S10 shows
mitotic exit, representative images, and kinetochore quantifi-
cations of pMELT and PLK1 in BUBR1-T620S and BUB1-T609S
mutants. Data S1 shows the full list of annotated and excluded
PBMs in eukaryotic MADBUB homologues. Data S2 shows the
KNL1 orthologues from Fig. S8 that are not published in Kops
et al. (2020), Tromer et al. (2015), and van Hooff et al. (2017).
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Figure S1. Effect of BUB1/BUBR1 knockdown in PLK1, BUBR1, and BUB1 kinetochore levels (related to Fig. 1). (A–C) Relative kinetochore levels of PKL1
(A), BUBR1 (B), and BUB1 (C) after siRNA-mediated depletion of BUB1, BUBR1, or both BUB1 and BUBR1 combined in HeLa FRT cells. Graphs show the mean
kinetochore intensity of 40–60 cells per condition, four experiments. For all kinetochore intensity graphs, each dot represents a cell, and the error bars display
the variation between the experimental repeats (displayed as ±SD of the experimental means). Two-tailed, nonparametric Mann-Whitney unpaired t tests
were performed to compare the means values between experimental groups. Example immunofluorescence images were chosen that most closely resemble
the mean values in the quantifications. The insets show magnifications of the outlined regions. Scale bars, 5 µm. Inset size, 1.5 µm. ****, P < 0.0001.
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Figure S2. Testing specificity of phospho-specific antibodies in cells and quantification of kinetochore BUB1 and BUBR1 levels in phosphatase-
bindingmutants (related to Fig. 1). (A)Mitotic cells expressing exogenous BUB1 and BUBR1 constructs were treated with/without 50 nM calyculin for 20min
before harvesting for lysis to maximally phosphorylate BUB1/BUBR1. YFP-tagged BUB1 and BUBR1, mutated in the Polo-box binding sites, were im-
munoprecipitated and blotted with indicated antibodies. Blots from a single experiment were chosen that best represent three independent experiments.
(B and C) Effect of mutating the Polo-box binding motifs (BUBR1T620A and BUB1T609A) on antibody detection of BUBR1 pT620 (B) and BUB1 pT609 (C) by
immunofluorescence. These experiments were performed in combination with either mutating the phosphatase binding motif on BUBR1 (B) or siRNA-mediated
knockdown of all B56 isoforms (C) to elevate BUBR1/BUB1 phosphorylation tomaximal levels. The graphs show the mean kinetochore intensity of 40 cells from
four experiments. (D and E) Kinetochore quantification of BUB1 (D) and BUBR1 (E) levels in phosphatase-binding mutants. D displays 30 cells from three
experiments, and E shows 30–40 cells from two or three experiments. For all kinetochore intensity graphs, each dot represents a cell, and the error bars
display the variation between the experimental repeats (displayed as ±SD of the experimental means). Two-tailed, nonparametric Mann-Whitney unpaired
t tests were performed to compare the means values between experimental groups. Example immunofluorescence images were chosen that most closely
resemble the mean values in the quantifications. The insets showmagnifications of the outlined regions. Scale bars, 5 µm. Inset size, 1.5 µm. **, P < 0.01; ****,
P < 0.0001.
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Figure S3. PLK1 inhibition or removal from BUB complex restores SAC silencing in the phosphatase-binding mutants (related to Fig. 2). (A) Example
immunofluorescence images of the kinetochore quantifications shown in Fig. 2 A. (B) Representative images and quantification of KNL1 (BUBR1WT/ΔPP2A cells)
or YFP-KNL1 (KNL1WT/ΔPP1 cells) after MPS1 inhibition with AZ-3146 (2.5 µM), as in Fig. 2 A. Graph represents 40 cells from four experiments.
(C) Representative immunofluorescence images of quantifications shown in Fig. 2 C. (D) Representative images and quantification of KNL1 (BUBR1 cells)
or YFP-KNL1 (KNL1 cells) after MPS1 inhibition with AZ-3146 (2.5 µM) in combination with the PLK1 inhibitor BI-2536 (100 nM), as in Fig. 2 C. Graph
represents 30 cells from three experiments. (E and F) Example immunofluorescence images of the kinetochore quantifications shown in Fig. 2 E (E) and
Fig. 2 G (F). (G and H) Quantification of KNL1 levels (G) and representative images (H) of BUBR1/BUB1 Polo-box–binding mutants treated with MPS1
inhibitor (2.5 µM AZ-3146), as in Fig. 2 G. Graph shows median of 40 cells per condition from four experiments. (I) Effect of mutating both PLK1 binding
sites BUBR1 (pT620) and BUB1 (pT609) on mitotic exit in nocodazole-arrested cells, treated with MPS1 inhibitor AZ-3146 (2.5 µM). Graph shows the
means (±SEM) of 150–200 cells from three or four experiments. The images were chosen that most closely resemble the mean values in the quanti-
fications. The insets show magnifications of the outlined regions. Scale bars, 5 µm. Inset size, 1.5 µm.
Cordeiro et al. Journal of Cell Biology S3
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Figure S4. Representative images from kinetochore quantifications in Fig. 4. (A and B) Example immunofluorescence images of the kinetochore
quantifications shown in Fig. 4 A (A) and Fig. 4 B (B). (C) Representative images and quantification of KNL1 (BUBR1 cells) or YFP-KNL1 (KNL1 cells) after
30 min pretreatment with PLK1 inhibitor followed by coinhibition with MPS1 and PLK1 inhibitors, as in Fig. 4 B. Graph represents 40 cells from four ex-
periments. (D–F) Immunofluorescence images of pMELT (D) and BUBR1 (E), and kinetochore quantification BUBR1 (F) from cells treated as in Fig. 4 C. Graph
shows median of 30–40 cells per condition from three or four experiments. (G–I) Representative immunofluorescence images of the kinetochore quantifi-
cations shown in Fig. 4 D (G), Fig. 4 E (H), and Fig. 4 F (I). MG132 was included in combination with MPS1 inhibitor in every case to prevent mitotic exit. For all
graphs, each dot represents a cell, and vertical bars show 95% CIs. All images were chosen that most closely resemble the mean values in the quantifications.
Scale bars, 5 µm. Inset size, 1.5 µm.
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Figure S5. Example images and kinetochore quantification of BUBR1 and RepoMan after calyculin A treatment with 25 nM and 50 nM doses (related
to Fig. 4). (A–D) Quantifications (A and C) and representative images (B and D) of YFP-RepoMan signal on chromatin and cytoplasm to confirm phosphatase
inhibition with 25 nM calyculin A (A and B) or 50 nM calyculin A (C and D) treatment regimens. Panel A represents 70 cells from four experiments, and C
represents 20–45 cells from two or three experiments. (E) Kinetochore BUBR1 quantifications from cells treated with 25 nM calyculin A as in Fig. 4 E. Graph
shows median of 40–50 cells per condition from four or five experiments. (F) Kinetochore levels of BUBR1 after phosphatase inhibition with 50 nM calyculin A.
Graph represents 30–60 cells per condition from three to six experiments. MG132 was included in combination with MPS1 inhibitor in every case to prevent
mitotic exit. For all graphs, each dot represents a cell, and vertical bars show 95% CIs. All images were chosen that most closely resemble the mean values in
the quantificaions. The insets show magnifications of the outlined regions. Scale bars, 5 µm. Inset size, 1.5 µm.
Cordeiro et al. Journal of Cell Biology S5
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Figure S6. Example images and kinetochore quantification KNL1 and KNL1-pMELT after calyculin A treatment with 25 nM and 50 nM doses (related
to Fig. 4). (A) Quantification of KNL1 levels in cells treated with 25 nM calyculin as in Fig. 4 E. Graph shows 30–40 cells per condition from three or four
experiments. (B and C) Kinetochore levels of KNL1 (B) and pMELT (C) after treatment with 50 nM calyculin A. B displays 30 cells from three experiments, and C
represents 50–70 cells from five to seven experiments. (D) Effects of PP2A-binding mutants in combination with the PP1/PP2A phosphatase inhibitor calyculin
A (50 nM) on pMELT dephosphorylation in nocodazole-arrested cells treated with PLK1 (100 nM BI-2536) and MPS1 (2.5 µM AZ-3146) inhibitors, as indicated in
the timeline. Graph displays kinetochore intensities of 30 cells per condition from three experimental repeats. MG132 was included in combination with MPS1
inhibitor in every case to prevent mitotic exit. For all graphs, each dot represents a cell, and vertical bars show 95% CIs. All images were chosen that most
closely resemble the mean values in the quantifications. The insets show magnifications of the outlined regions. Scale bars, 5 µm. Inset size, 1.5 µm.
Cordeiro et al. Journal of Cell Biology S6




 http://rupress.org/jcb/article-pdf/219/12/e202002020/1405117/jcb_202002020.pdf by guest on 02 N
ovem
ber 2020
Figure S7. Model for how localized processes could use a combination of regulated and unregulated phosphatase activity to synchronously de-
phosphorylate spatially resolved substrates (related to Fig. 4).
Cordeiro et al. Journal of Cell Biology S7
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Figure S8. Annotation of putative PBMs and PP2A-B56 binding motifs (KARD) within eukaryotic MADBUB homologues (related to Fig. 5). Adapted
from Tromer et al. (2016).
Cordeiro et al. Journal of Cell Biology S8
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Figure S9. Sequence alignment of all PBM in eukaryotic MADBUB homologues with respect to position from the KARD (related to Fig. 5). (A) Dis-
tribution of the PBMs with respect to the distance from the KARD position (zero). Positive values represent PBM after KARD and negative values represent PBM
before KARD. (B and C) Consensus sequence (B) and sequence alignment (C) of the PBM depending on the relative position from KARDmotif. (D) PBM sequence
alignment of vertebrate BUBs without a KARD.
Cordeiro et al. Journal of Cell Biology S9
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Figure S10. Thr-to-Ser conversion in the PBM of BUB1 or BUBR1 does not increase PLK1 levels or delay MELT dephosphorylation after MPS1 in-
hibition (related to Fig. 5). (A and B) Effect of Thr-to-Ser conversion in BUB1 (T609S) on kinetochore levels of pMELT (A) and PLK1 (B) after MPS1 inhibition
with 2.5 µM AZ-3146. A shows 30 cells per condition from three experiments, and B represents 30–40 cells from three or four experiments. (C) MELT
phosphorylation levels in BUB1-T609S cells after 5 min of MPS1 inhibition with different concentrations of AZ-3146 (0.3–5 µM) in nocodazole-arrested cells.
Graphs display kinetochore intensities of 30 cells, three experiments. (D and E) Effect of Thr-to-Ser conversion in BUBR1 (T620S) in pMELT (D) and PLK1 (E)
levels after MPS1 inhibition (2.5 µM AZ-3146). D represents 30 cells from three experiments, and E shows 40 cells from four experiments. (F) MELT phos-
phorylation levels in BUBR1-T620S cells after 5 min of MPS1 inhibition with different concentrations of AZ-3146 (0.3–5 µM) in nocodazole-arrested cells.
Graphs display kinetochore intensities of 20–30 cells, two or three experiments. (G and H) Effect of BUBR1-T620S (G) and BUB1-T609S (H) mutations on
mitotic exit in nocodazole-arrested cells treated with MPS1 inhibitor (2.5 µM AZ-3146). G shows the means (±SEM) of 150 cells from three experiments, and H
shows 200 cells from four experiments. MG132 was included in combination with MPS1 inhibitor in every case to prevent mitotic exit. For all graphs, each dot
represents a cell, and vertical bars show 95% CIs. All images were chosen that most closely resemble the mean values in the quantifications. Scale bars, 5 µm.
Inset size, 1.5 µm.
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Data S1 shows the full list of annotated and excluded PBMs in eukaryotic MADBUB homologues. Data S2 shows the KNL1
orthologues from Fig. S8 that are not published in Kops et al. (2020), Tromer et al. (2015), or van Hooff et al. (2017).
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